PhRMA Funnels Millions to Groups Fighting Drug Pricing Reforms
The pharma lobby gave more than $16 million in 2022 to advocacy groups, many of them ostensibly “grassroots,” that are battling the Medicare drug price negotiations now underway.
Big Pharma
Pfizer Spends Big on IP Lobbying With Billions on the Line
The pharmaceutical giant spent big bucks amid key international negotiations last year to protect record earnings.
Corporate Dems’ Rapidly Growing ‘Dark Money’ Arm
Tax documents reveal the group Center Forward received a record $18.8 million in 2021 and spent big to back conservative Democrats who bucked their party on drug pricing reforms.
News Outlet Founded by Blue Dog Dem Operatives Promotes Big Pharma's Lobbying Aims
Leaders of a centrist advocacy group with funding from the pharmaceutical industry founded outlet The Well News and have editorial input on its promoted posts.
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
Dems Signaling Opposition to Pelosi’s Drug Pricing Bill Got 2.5x More Pharma Money
